Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dae Ho Lee

Showing results (131-140 of 353) with videos related to

Pageof 36
Sort By:
The Journal of Urology|November 16, 2010
The value of cytoreductive nephrectomy for metastatic renal cell carcinoma in the era of targeted therapyDalsan You, In Gab Jeong, Jin-Hee Ahn, et al.
Journal of Cancer Research and Clinical Oncology|June 26, 2020
Clinical outcomes of nivolumab in patients with advanced non-small cell lung cancer in real-world practice, with an emphasis on hyper-progressive diseaseSoo Han Kim, Chang-Min Choi, Dae Ho Lee, et al.
Cancer Research and Treatment|April 29, 2016
Ipilimumab Real-World Efficacy and Safety in Korean Melanoma Patients from the Korean Named-Patient Program CohortMinkyu Jung, Jeeyun Lee, Tae Min Kim, et al.
Cancer Research and Treatment|December 5, 2022
Optimal Definition of Oligometastasis Showing Survival Benefits of Local Therapies during Tyrosine Kinase Inhibitor TreatmentYoon Jung Jang, Dong-Gon Hyun, Wonjun Ji, et al.
Plos One|April 17, 2020
Outcomes according to initial and subsequent therapies following intracranial progression in patients with EGFR-mutant lung cancer and brain metastasisDong-Gon Hyun, Chang-Min Choi, Dae Ho Lee, et al.
Cancer Letters|August 12, 2017
The HSP90 inhibitor, NVP-AUY922, attenuates intrinsic PI3K inhibitor resistance in KRAS-mutant non-small cell lung cancerKang-Seo Park, Hannah Yang, Junyoung Choi, et al.
Oncotarget|August 27, 2015
Transcriptome analysis indicates TFEB1 and YEATS4 as regulatory transcription factors for drug resistance of ovarian cancerYi Rang Kim, Mi Sung Park, Ki Hwan Eum, et al.
Translational Lung Cancer Research|July 23, 2021
Different prognostic implications of hepatic metastasis according to front-line treatment in non-small cell lung cancer: a real-world retrospective studyMyeong Geun Choi, Chang-Min Choi, Dae Ho Lee, et al.
Diabetes & Metabolism Journal|June 30, 2024
Association of Succinate and Adenosine Nucleotide Metabolic Pathways with Diabetic Kidney Disease in Patients with Type 2 Diabetes MellitusInha Jung, Seungyoon Nam, Da Young Lee, et al.
Cancer Medicine|July 25, 2023
Safety and tolerability of first-line durvalumab with tremelimumab and chemotherapy in esophageal squamous cell carcinomaDae Ho Lee, Hye Ryun Kim, Bhumsuk Keam, et al.
Pageof 36

Showing results (131-140 of 353) with videos related to

Sort By:
Pageof 36
The Journal of Urology|November 16, 2010
The value of cytoreductive nephrectomy for metastatic renal cell carcinoma in the era of targeted therapyDalsan You, In Gab Jeong, Jin-Hee Ahn, et al.
Journal of Cancer Research and Clinical Oncology|June 26, 2020
Clinical outcomes of nivolumab in patients with advanced non-small cell lung cancer in real-world practice, with an emphasis on hyper-progressive diseaseSoo Han Kim, Chang-Min Choi, Dae Ho Lee, et al.
Cancer Research and Treatment|April 29, 2016
Ipilimumab Real-World Efficacy and Safety in Korean Melanoma Patients from the Korean Named-Patient Program CohortMinkyu Jung, Jeeyun Lee, Tae Min Kim, et al.
Cancer Research and Treatment|December 5, 2022
Optimal Definition of Oligometastasis Showing Survival Benefits of Local Therapies during Tyrosine Kinase Inhibitor TreatmentYoon Jung Jang, Dong-Gon Hyun, Wonjun Ji, et al.
Plos One|April 17, 2020
Outcomes according to initial and subsequent therapies following intracranial progression in patients with EGFR-mutant lung cancer and brain metastasisDong-Gon Hyun, Chang-Min Choi, Dae Ho Lee, et al.
Cancer Letters|August 12, 2017
The HSP90 inhibitor, NVP-AUY922, attenuates intrinsic PI3K inhibitor resistance in KRAS-mutant non-small cell lung cancerKang-Seo Park, Hannah Yang, Junyoung Choi, et al.
Oncotarget|August 27, 2015
Transcriptome analysis indicates TFEB1 and YEATS4 as regulatory transcription factors for drug resistance of ovarian cancerYi Rang Kim, Mi Sung Park, Ki Hwan Eum, et al.
Translational Lung Cancer Research|July 23, 2021
Different prognostic implications of hepatic metastasis according to front-line treatment in non-small cell lung cancer: a real-world retrospective studyMyeong Geun Choi, Chang-Min Choi, Dae Ho Lee, et al.
Diabetes & Metabolism Journal|June 30, 2024
Association of Succinate and Adenosine Nucleotide Metabolic Pathways with Diabetic Kidney Disease in Patients with Type 2 Diabetes MellitusInha Jung, Seungyoon Nam, Da Young Lee, et al.
Cancer Medicine|July 25, 2023
Safety and tolerability of first-line durvalumab with tremelimumab and chemotherapy in esophageal squamous cell carcinomaDae Ho Lee, Hye Ryun Kim, Bhumsuk Keam, et al.
Pageof 36